If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAegon Ord Regulatory News (0Q0Y)

Share Price Information for Aegon Ord (0Q0Y)

Share Price is delayed by 15 minutes
Get Live Data
7.69    -0.025 (-0.32%)
Bid:
7.31
Ask:
8.07
Spread: 0.76 (10.397%)
Market Cap: €11.37b
0Q0Y Live PriceLast checked at - London Stock Exchange

Intraday Aegon Ord Share Chart

  • This share is an international stock.

New management structure AEGON UK

7 Dec 2009 07:00

New management structure AEGON UK

THE HAGUE - In line with AEGON's strategy, AEGON UK continues to focus on efficient capital management and improving returns on capital. Toward this end, AEGON has created two separate functions within its UK Risk and Finance operations, each with local Management Board level responsibility. The new Risk operation will bring a clear focus on risk, capital management and improving returns. This development will ensure AEGON is prepared for future changes to the regulatory environment in the UK insurance sector.

Mark Laidlaw, AEGON UK's Chief Financial Officer will take on the new Management Board role of Chief Risk Officer and will lead and develop risk and capital management strategy within AEGON UK.

AEGON has appointed Bill Robertson to the role of Finance Director. Mr. Robertson is currently Chief Actuary for AEGON N.V., a role he has held since 2004. He previously held a succession of senior finance and actuarial roles within AEGON UK.

Both Mark Laidlaw and Bill Robertson will report to AEGON UK chief executive Otto Thoresen.

Commenting on the changes, Otto Thoresen, AEGON UK CEO and a member of AEGON's Management Board, said, "It is clear that AEGON UK needs to improve return on capital in line with AEGON's global approach, following the impact of falls in the financial markets. AEGON's strategy is to improve returns and to de-risk our balance sheet. Creating a new focus on risk and capital management will enable us to achieve these dual goals. With the new management focus, AEGON UK is well placed for the future."

Notes to editors

Mark Laidlaw was appointed Chief Financial Officer in January 2005, and in this role, led AEGON UK's finance, actuarial and risk functions. Mark joined AEGON in 1988 and has held a number of key financial roles.

Bill Robertson joins AEGON UK from AEGON N.V. where he was previously Chief Actuary. Prior to that he held a number of senior finance and actuarial roles within AEGON UK. He joined AEGON in 1999.

Contact informationMedia relations: Greg Tucker+31(0)70 344 8956gcc-ir@aegon.com

Investor relations: Gerbrand Nijman

+31 (0)70 344 8305

877 548 9668 - toll free USA only

ir@aegon.comWebsite: www.aegon.comAbout AEGON

As an international life insurance, pension and investment company based in

The Hague, AEGON has businesses in over twenty markets in the Americas,

Europe and Asia. AEGON companies employ approximately 29,000 people

and have over 40 million customers across the globe.

Key figures - EUR Q3 2009 Full year 2008 Underlying earnings 351 1.6 billionbefore tax million New life sales 484 2.6 billion million Gross deposits 6.8 40.8 billion billion Revenue generating investments 354 332 billion(end of period) billion

Forward-looking statements

The statements contained in this press release that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to our company. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. We undertake no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:

* Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom; * Changes in the performance of financial markets, including emerging markets, such as with regard to: - The frequency and severity of defaults by issuers in our fixed income investment portfolios; and - The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities we hold; * The frequency and severity of insured loss events; * Changes affecting mortality, morbidity and other factors that may impact the profitability of our insurance products; * Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels; * Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates; * Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets; * Changes in laws and regulations, particularly those affecting our operations, the products we sell, and the attractiveness of certain products to our consumers; * Regulatory changes relating to the insurance industry in the jurisdictions in which we operate; * Acts of God, acts of terrorism, acts of war and pandemics; * Effects of deliberations of the European Commission regarding the aid we received from the Dutch State in December 2008; * Changes in the policies of central banks and/or governments; * Litigation or regulatory action that could require us to pay significant damages or change the way we do business; * Customer responsiveness to both new products and distribution channels; * Competitive, legal, regulatory, or tax changes that affect the distribution cost of or demand for our products; * Our failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving initiatives; and * The impact our adoption of the International Financial Reporting Standards may have on our reported financial results and financial condition.

Further details of potential risks and uncertainties affecting the company are described in the company's filings with Euronext Amsterdam and the US Securities and Exchange Commission, including the Annual Report on Form 20-F. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

DECEMBER 7, 2009

vendor
12
Date   Source Headline
29th Jun 20127:00 amPRNAEGON's listing on the London Stock Exchange cancelled
19th Jun 20127:00 amPRNAEGON defines path for capturing growth in core markets
8th Jun 20126:30 pmPRNStock fraction final dividend 2011 AEGON at 1/33
31st May 20127:00 amPRNAEGON accelerates improvements NL unit-linked policies
23rd May 20127:00 amPRNAEGON to cancel its listing on the LSE
16th May 20124:00 pmPRNSummary of Annual General Meeting of Shareholders
10th May 20127:00 amPRNAEGON's 2011 total EV increased 10% to EUR 20.7 billion
10th May 20127:00 amPRNQ1 2012 Results
12th Apr 20127:00 amPRNAEGON recategorizes reporting Asian operations
4th Apr 20127:00 amPRNAEGON N.V. publishes agenda AGM
23rd Mar 20123:15 pmPRNAEGON files Annual Report 2011
17th Feb 20127:00 amPRNAEGON maintains strong capital position
17th Feb 20127:00 amPRNAEGON UK CEO Adrian Grace appointed to Management Board
27th Jan 20127:00 amPRNAEGON into EUR 2 billion syndicated credit facility
25th Jan 20127:15 amPRNUSD 500 mln 8% non-cumulative subordinated notes
6th Dec 20117:00 amPRNAEGON to reaffirm targets at annual investor conference
24th Nov 20117:00 amPRNAEGON completes sale of Guardian in the UK
10th Nov 20117:00 amPRN3rd Quarter Results
29th Sep 20117:30 amPRNAEGON to Restructure Business in the Netherlands
16th Aug 20117:00 amPRNAEGON to Sell Closed UK Life Insurance Business Guardian
11th Aug 20117:00 amPRNQ2 2011 Results
10th Aug 20117:00 amPRNAEGON completes divestment of Transamerica Reinsurance
8th Aug 20117:00 amPRNMr Docters van Leeuwen steps down from Supervisory Board
15th Jun 20117:00 amPRNAEGON completes repayment to Dutch State
12th May 20115:25 pmPRNSummary of Annual General Meeting of Shareholders
12th May 20117:00 amPRNAEGON announces Q1 net income of EUR 327 million
12th May 20117:00 amPRNAEGON's 2010 Total Embedded Value Increased to EUR18.9bn
26th Apr 20117:00 amPRNAEGON to divest Transamerica Reinsurance to SCOR
14th Apr 20117:00 amPRNCompletes Sale of EUR1.5 bn `SAECURE 10' RMBS notes
31st Mar 20113:00 pmPRNAEGON’s 2010 Form 20-F and Annual Report available
31st Mar 20117:00 amPRNNominations EB and SB AEGON N.V.
16th Mar 20117:00 amPRNAEGON repurchased EUR750 mln core capital securities
8th Mar 20117:00 amPRNAEGON appoints Adrian Grace CEO AEGON UK
24th Feb 20113:50 pmPRNAEGON completes 10% equity issue
24th Feb 20117:00 amPRNAEGON announces strong Q4 2010 results
24th Feb 20117:00 amPRNAEGON to launch equity issue of 10%
16th Feb 20117:00 amPRNAEGON Supervisory Board Member Cecelia Kempler to Resign
16th Dec 201011:42 amPRNAEGON UK response to FSA notice re Scottish Equitable
8th Dec 20107:00 amPRNAEGON to detail progress in execution of strategy
2nd Dec 20107:00 amPRNAEGON to sharpen focus on core activities in US
27th Sep 20104:45 pmPRNAEGON completes sale of EUR 842 million RMBS notes
7th Sep 20107:00 amPRNAEGON appoints Global Head of Sustainability
31st Aug 20107:00 amPRNAEGON repays EUR 500 million of government support
17th Aug 20107:00 amPRNAEGON concludes approval process European Commission
12th Aug 20107:00 amPRNAEGON posts strong results for second quarter 2010
13th Jul 20107:00 amPRNMs Russell appointed CEO AEGON Asset Management business
8th Jul 20107:00 amPRNAEGON completes sale of EUR 1 billion RMBS notes
6th Jul 20107:00 amPRNAEGON appoints global head of human resources
22nd Jun 20107:00 amPRNStatement re Strategy
1st Jun 20107:00 amPRNAEGON appoints Clare Bousfield CFO in UK
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.